Tomiyama Y - Search Results

1

Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Provan D, et al. Among authors: tomiyama y. Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812. Blood Adv. 2019. PMID: 31770441 Free PMC article.

2

Analyses of thrombocytopenia in idiopathic thrombocytopenic purpura-prone mice by platelet transfer experiments between (NZW x BXSB)F1 and normal mice.

Mizutani H, Furubayashi T, Kuriu A, Take H, Tomiyama Y, Yoshida H, Nakamura Y, Inaba M, Kurata Y, Yonezawa T, et al. Mizutani H, et al. Among authors: tomiyama y. Blood. 1990 May 1;75(9):1809-12. Blood. 1990. PMID: 2331522 Free article.

3

Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb.

Kosugi S, Tomiyama Y, Honda S, Kato H, Kiyoi T, Kashiwagi H, Kurata Y, Matsuzawa Y. Kosugi S, et al. Among authors: tomiyama y. Blood. 2001 Sep 15;98(6):1819-27. doi: 10.1182/blood.v98.6.1819. Blood. 2001. PMID: 11535516 Free article.

4

Treatment of primary autoimmune thrombocytopenia (AITP) [1].

Schipperus MR, Fijnheer R, Pabinger I, Godeau B, Michel M, Tomiyama Y, Imbach P, Cuker A, Cines B, Panzer S, Reesink HW. Schipperus MR, et al. Among authors: tomiyama y. Vox Sang. 2012 Apr;102(3):261-8. doi: 10.1111/j.1423-0410.2011.1552.x. Epub 2011 Nov 4. Vox Sang. 2012. PMID: 22050204 No abstract available.

5

Recognition of highly restricted regions in the β-propeller domain of αIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia.

Kiyomizu K, Kashiwagi H, Nakazawa T, Tadokoro S, Honda S, Kanakura Y, Tomiyama Y. Kiyomizu K, et al. Among authors: tomiyama y. Blood. 2012 Aug 16;120(7):1499-509. doi: 10.1182/blood-2012-02-409995. Epub 2012 Jun 22. Blood. 2012. PMID: 22730538 Free article.

6

Pathophysiology and management of primary immune thrombocytopenia.

Kashiwagi H, Tomiyama Y. Kashiwagi H, et al. Among authors: tomiyama y. Int J Hematol. 2013 Jul;98(1):24-33. doi: 10.1007/s12185-013-1370-4. Epub 2013 May 24. Int J Hematol. 2013. PMID: 23702914 Review.

7

Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders.

Sakuragi M, Hayashi S, Maruyama M, Kabutomori O, Kiyokawa T, Nagamine K, Kato H, Kashiwagi H, Kanakura Y, Tomiyama Y. Sakuragi M, et al. Among authors: tomiyama y. Int J Hematol. 2015 Apr;101(4):369-75. doi: 10.1007/s12185-015-1741-0. Epub 2015 Jan 25. Int J Hematol. 2015. PMID: 25618218

8

[Recent advances in pathophysiology and treatment of immune thrombocytopenia].

Kashiwagi H, Tomiyama Y. Kashiwagi H, et al. Among authors: tomiyama y. Rinsho Ketsueki. 2015 Feb;56(2):177-84. doi: 10.11406/rinketsu.56.177. Rinsho Ketsueki. 2015. PMID: 25765798 Review. Japanese.

9

Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.

Michel M, Wasser J, Godeau B, Aledort L, Cooper N, Tomiyama Y, Khellaf M, Wang X. Michel M, et al. Among authors: tomiyama y. Ann Hematol. 2015 Dec;94(12):1973-80. doi: 10.1007/s00277-015-2485-x. Epub 2015 Sep 4. Ann Hematol. 2015. PMID: 26341755 Clinical Trial.

10

[Current topics in primary immune thrombocytopenia].

Tomiyama Y. Tomiyama Y. Rinsho Ketsueki. 2017;58(5):537-541. doi: 10.11406/rinketsu.58.537. Rinsho Ketsueki. 2017. PMID: 28592772 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page